Professor Dr. Jagdish N. Sharma
Faculty of Pharmacy
Health Sciences Centre, Jabriya
Dr. Jagdish N. Sharma is currently a Professor in the Department of Pharmacology and Therapeutics of which he is the Founding Chairman, Faculty of Pharmacy, Kuwait University, Kuwait. He has also served as a Professor of Pharmacology at the Universiti Sains Malaysia, Penang, Malaysia, prior to joining Kuwait University in 1999. Prof. Sharma received his B.V.Sc. & A.H. (D.V.M.) in 1970 from Jawaharlal Nehru Agricultural University, Jabalpur, India; his M.Sc. in Medical Pharmacology in 1973 from the All-India Institute of Medical Sciences, New Delhi, India; and his Ph.D. in Pharmacology in1976 from the University of Strathclyde, Glasgow, Scotland, UK. The Calamus International University, London, U. K., in 2011, awarded D.Sc. degree in Health Sciences to Professor Sharma in recognition of his outstanding highly accomplished professional achievements in research and academic contributions. In 1995, he was elected to an F.C.P. (Fellow) from the American College of Clinical Pharmacology, New York, USA and an F.I.Biol. (Fellow) in 1997 from the Royal Institute of Biology, London, UK. This is a highly prestigious award considered to be at the level of British DSc.
Prof. Sharma is an author of a book entitled “Topics in Mediators Pharmacology”, which has been published by the Nova Science Publishers Inc., N.Y., USA. Prof. Sharma is the Editor of a book Progress in Drug Research” series entitled “Recent Developments in the Regulation of Kinins” 2014 which is published by Springer Basel AG, Switzerland. He has been to numerous International conferences as invited speaker. Prof. Sharma has been holding several research grants for the support of his clinical and basic research activities and supervised PhD and MSc theses. He has been PhD external examiner and evaluator for promotions to the ranks of Associate Professor and Professor externally. In Malaysia, his research investigations were funded by the Ministry of Science and Technology, Malaysia. Currently his clinical priority research grant is funded by the Kuwait University research sector. He is the editorial board member of Pharmacy Times (USA) of Middle East from 2007 to date, Inflammopharmacology (UK) from 1997 to date, International Journal of Immunopathology and Pharmacology (Italy) from 2006 to date, European Journal of Inflammation (Italy) from 2006 to date, Archives of Medical Research (Mexico City) from 2006 to date, Clinical Medicine: Endocrinology and Diabetes (New Zealand) from 2008 to date, Clinical Medicine: Therapeutics (New Zealand) from 2009 to date, American Journal of Biomedical Sciences (USA) from 2009 to date and Journal of Pharmaceutical Technology and Drug Research (UK) from 2011 to date. He has 111 publications in reputed international biomedical journals, and 65 abstracts of national and international conferences. His work is supported by the Kuwait University Grant RP01/09.
Diabetes has been implicated as a major risk factor in the development of cardiovascular and renal complications.
Prof. Yahaya Hassan
Pharmacy Practice Department at Faculty of Pharmacy,
Universiti Teknologi MARA (UiTM),
Dr Yahaya Hassan is a Professor of Clinical Pharmacy, Pharmacy Practice Department at Faculty of Pharmacy,Universiti Teknologi MARA (UiTM), Malaysia. He also serve as a consultant for Malaysian Qualifying Agency (MQA) Ministry of Higher Education of Malaysia and MQA panel member for Board of Pharmacy of Malaysia. He also serve as a committee member of Clinical Pharmacy Specialist development program for Pharmacy Division,Ministry of Health of Malaysia. Prof Yahaya obtained his B.Pharm from Universiti Sains Malaysia and Pharm.D. from University of Minnesota, USA. He has been lecturing at the faculty of Pharmacy for 33 years covering courses in clinical pharmacy, pharmacokinetics, advanced pharmacotherapeutics and pharmacy practice. He has successfully supervised over 30 research postgraduate students at the master’s and Ph.D levels, more than 200 master’s by coursework and published over 120 research papers in international journals and regional and local journals.
His current research interest focus on clinical pharmacy, clinical pharmacokinetic, pharmacoepidemiology and pharmaceutical outcome study.
Clinical pharmacy is the science and practice of rational medication use. It is a patient-oriented, evidence-based practice that uses the medication-related expertise of pharmacists to enhance patient outcomes and improve quality of life. Clinical pharmacy practices were expanding, thereby creating a growing unmet need for pharmacists who had been educated and trained in clinical pharmacy.
Prof. Hong Qi Zhang,
School of Chinese Medicine,
Hong Kong Baptist University,
Hong Kong, China
After graduation as a MBBS and practice surgery for 5 years in 1980s, Professor HQ Zhang pursued his Master of Surgery and PhD degrees from University of New South Wales, Australia, and has been working in School of Chinese Medicine, Hong Kong Baptist University since 1999. His early research focuses on pain mechanisms, and in recent years on stem cell for neurodegenerative diseases and drug delivery for cancer treatment, leading to many publications.
Hepatocellular carcinoma (HCC) is notoriously difficult to treat due usually late detection and drug resistance to chemotherapy, making one of the cancers with top mortality rate.
Muralikrishnan Angamuthu, M.S., Ph.D.
Muralikrishnan Angamuthu is currently working as Research Investigator in GlaxoSmithKline Inc. He specializes in drug product design, formulation and process development, IVIVC, scale-up and technology transfer of solid oral products. His research interests include controlled release formulations, powder technology, and pharmaceutical processes including dry/wet granulation, hot melt extrusion and coating. He has more than 8 years of pioneering research experience in various drug product formulations.
Muralikrishnan has authored and/or coauthored several research articles and two text book chapters in the area of QbD, formulation development and drug delivery. He has made several technical presentations at national and international conferences and serves as an official reviewer for several journals in the field of drug delivery and pharmaceutical sciences. He is a recipient of predoctoral fellowship from National Institutes of Health, Center of Research Excellence in Natural Products and Neuroscience 2013.
Muralikrishnan received his Doctorate in pharmaceutics & drug delivery from the University of Mississippi; M.S. in Pharmaceutics & Industrial Pharmacy from Long Island University, NY and B.S. in Pharmaceutical Sciences from Dr. M.G.R. Medical University, India.